Ho Shing Wong

Ho Shing Wong

Auto-generated profile, based on publicly available information

Ho Shing Wong

Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. 1

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
HLHorace H.Y. Lee
Horace H.Y. Lee
KCKin Long Chow
Kin Long Chow
HWHo Shing Wong
Ho Shing Wong
TCTsz Yan Chong
Tsz Yan Chong
AWAlice Sze-Tsai Wong
Alice Sze-Tsai Wong
PIPhilip Pun Ching Ip
Philip Pun Ching Ip
Purpose: Uterine leiomyosarcoma (LMS) is an aggressive sarcoma and a subset of which exhibits DNA repair defects. Polo-like kinase 4 (PLK4) precisely modulates mitosis, and its inhibition causes chromosome missegregation and increased DNA damage. We hypothesize that PLK4 inhibition is an effective LMS treatment. Experimental Design: Genomic profiling of clinical uterine LMS samples was performed, and homologous recombination (HR) deficiency scores were calculated. A PLK4 inhibitor (CFI-400945) with and without an ataxia telangiectasia mutated (ATM) inhibitor (AZD0156) was tested in vitro on gynecologic sarcoma cell lines SK-UT-1, SKN, and SK-LMS-1. Findings were validated in vivo using the SK-UT-1 xenograft model in the Balb/c nude mouse model. The effects of CFI-400945 were also evaluated in a BRCA2-knockout SK-UT-1 cell line. The mechanisms of DNA repair were analyzed using a DNA damage reporter assay. Results: Uterine LMS had a high HR deficiency score, overexpressed PLK4 mRNA, and displayed mutations in genes responsible for DNA repair. CFI-400945 demonstrated effective antitumor activity in vitro and in vivo. The addition of AZD0156 resulted in drug synergism, largely due to a preference for nonhomologous end-joining DNA repair. Compared with wild-type cells, BRCA2 knockouts were more sensitive to PLK4 inhibition when both HR and nonhomologous end-joining repairs were impaired. Conclusions: Uterine LMS with DNA repair defects is sensitive to PLK4 inhibition because of the effects of chromosome missegregation and increased DNA damage. Loss-of-function BRCA2 alterations or pharmacologic inhibition of ATM enhanced the efficacy of the PLK4 inhibitor. Genomic profiling of an advanced-stage or recurrent uterine LMS may guide therapy.

3 September 2024
Verified
Other
Open access
PDF file
HLHorace H.Y. Lee
Horace H.Y. Lee
KCKin Long Chow
Kin Long Chow
HWHo Shing Wong
Ho Shing Wong
TCTsz Yan Chong
Tsz Yan Chong
AWAlice Sze-Tsai Wong
Alice Sze-Tsai Wong
PIPhilip Pun Ching Ip
Philip Pun Ching Ip
Supplementary Figure S5. Oncoplot of key genes responsible for DNA repair among sarcoma cell lines.

3 September 2024
Verified
Other
Open access
PDF file
HLHorace H.Y. Lee
Horace H.Y. Lee
KCKin Long Chow
Kin Long Chow
HWHo Shing Wong
Ho Shing Wong
TCTsz Yan Chong
Tsz Yan Chong
AWAlice Sze-Tsai Wong
Alice Sze-Tsai Wong
PIPhilip Pun Ching Ip
Philip Pun Ching Ip
Supplementary Figure S1. Sanger sequencing of SK-UT-1 and SKN BRAC2-KO.

3 September 2024
Verified
Other
Open access
PDF file
HLHorace H.Y. Lee
Horace H.Y. Lee
KCKin Long Chow
Kin Long Chow
HWHo Shing Wong
Ho Shing Wong
TCTsz Yan Chong
Tsz Yan Chong
AWAlice Sze-Tsai Wong
Alice Sze-Tsai Wong
PIPhilip Pun Ching Ip
Philip Pun Ching Ip
Supplementary Figure S2. DNA content and centrosome number quantification in myogenic sarcoma cell lines after CFI-400945 treatment.

3 September 2024
Verified
Other
Open access
PDF file
HLHorace H.Y. Lee
Horace H.Y. Lee
KCKin Long Chow
Kin Long Chow
HWHo Shing Wong
Ho Shing Wong
TCTsz Yan Chong
Tsz Yan Chong
AWAlice Sze-Tsai Wong
Alice Sze-Tsai Wong
PIPhilip Pun Ching Ip
Philip Pun Ching Ip
Supplementary Figure S3. Autopsy findings on a representative mouse treated with 7.5 mg/kg CFI-400945 (hematoxylin and eosin staining).

3 September 2024
Verified
Other
Open access
HLHorace H.Y. Lee
Horace H.Y. Lee
KCKin Long Chow
Kin Long Chow
HWHo Shing Wong
Ho Shing Wong
TCTsz Yan Chong
Tsz Yan Chong
AWAlice Sze-Tsai Wong
Alice Sze-Tsai Wong
PIPhilip Pun Ching Ip
Philip Pun Ching Ip
Supplementary Table S1. Clinicopathologic features of 25 uterine leiomyosarcoma.